Grazoprevir/elbasvir highly effective in treatment-experienced and HIV-coinfected hepatitis C patients
First HIV home test approved for sale in UK
Many people living with HIV willing to take part in cure research, despite its risks
Grazoprevir / elbasvir highly effective in previously untreated hepatitis C
Men taking HIV treatment have undetectable viral loads in the rectum; sexually transmitted infections make no difference
Sofosbuvir/ledipasvir plus ribavirin shows high cure rate for hepatitis C patients with advanced liver disease
Merck HCV combination achieves 90% cure in advanced cirrhosis
Merck HCV combination effective after failure of first generation of direct-acting antivirals
